Stevanato Group presents Vertiva™, a versatile on-body delivery system platform for a wide range of injectable therapies and for large delivery volumes (up to 10mL)

The Company offers the platform as a readily customizable pre-filled and pre-loaded on-body solution for drug delivery. Device development is making significant progress, with samples expected to be available in 2023.

Visit Stevanato Group’s website https://www.stevanatogroup.com/en/offering/drug-delivery-systems/proprietary-and-licensed-devices/vertiva/ to learn more about Vertiva™ and request information on samples.